Agilent 23 ene 2026 Agilent launches high-capacity slide scanner for European pathology labs - Investing.com
Agilent 23 ene 2026 Agilent Accelerates Digital Pathology with the Launch of the Agilent S540MD Slide Scanner System - voiceofalexandria.com
Agilent 23 ene 2026 Agilent Accelerates Digital Pathology with the Launch of the Agilent S540MD Slide Scanner System - Business Wire
Agilent 23 ene 2026 Omics Lab Services: Global Market Review 2021-2025 and Forecast 2026-2031 Featuring Profiles of Agilent Technologies, Q2 Solutions, Flomics Biotech, QIAGEN, Thermo Fisher Scientific and More - Yahoo Finance
Agilent 23 ene 2026 Rakuten Investment Management Inc. Purchases New Shares in Agilent Technologies, Inc. $A - MarketBeat
Agilent 22 ene 2026 Agilent Technologies (NYSE:A) Stock Rating Upgraded by Hsbc Global Res - MarketBeat
Agilent 22 ene 2026 Agilent Technologies (NYSE:A) sheds 4.2% this week, as yearly returns fall more in line with earnings growth - Yahoo Finance
Agilent 22 ene 2026 Agilent Technologies (A) Valuation Check After Analyst Upgrades And Upcoming Fiscal Q1 Earnings - simplywall.st
Agilent 22 ene 2026 Agilent Technologies (A) Valuation Check After Analyst Upgrades And Upcoming Fiscal Q1 Earnings - simplywall.st
Agilent 22 ene 2026 Agilent Technologies (A) Valuation Check After Analyst Upgrades And Upcoming Fiscal Q1 Earnings - Sahm
Agilent 21 ene 2026 Universal Beteiligungs und Servicegesellschaft mbH Sells 9,703 Shares of Agilent Technologies, Inc. $A - MarketBeat
Agilent 21 ene 2026 Earnings Preview: What to Expect From Agilent Technologies' Report - Barchart.com
Agilent 21 ene 2026 Forensic Technology Market Is Going to Boom | Agilent Technologies • QIAGEN • Bio-Rad Laboratories • LGC Limited - openPR.com
Agilent 21 ene 2026 Allstate Corp Purchases Shares of 9,640 Agilent Technologies, Inc. $A - MarketBeat
Agilent 20 ene 2026 Agilent, Danaher could be potential buyers of Qiagen - analyst (QGEN:NYSE) - Seeking Alpha
Agilent 20 ene 2026 HSBC Initiates Coverage of Agilent Technologies (A) with Buy Recommendation - Nasdaq